Reimagining Ophthalmology Trials Through Decentralization

Decentralized clinical trials (DCTs) are transforming how ophthalmology research reaches patients. For conditions like diabetic retinopathy, age-related macular degeneration and glaucoma, timely and repeated imaging is central to measuring endpoints. Historically this tethered patients to specialist centers.

At Proclin Research, our flagship ophthalmology program blends home-based OCT capture, tele-ophthalmology review and validated ePRO instruments to reduce the burden on participants while preserving data integrity. Portable imaging, coupled with central reading centers, allows consistent, blinded assessment across geographies.

Crucially, decentralization does not mean compromising compliance. Every workflow is built to satisfy 21 CFR Part 11, ICH-GCP and GDPR — with audit trails, e-consent and encryption baked in. The result is faster enrollment, richer longitudinal data and broader equity of access for patients who previously could not travel.